| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Shock, Septic | 7 | 2020 | 1313 | 1.64 | Why? |
| Intensive Care Units | 23 | 2021 | 29594 | 0.74 | Why? |
| Whole Body Imaging | 1 | 2018 | 116 | 0.69 | Why? |
| Abdominal Injuries | 1 | 2018 | 72 | 0.69 | Why? |
| Thoracic Injuries | 1 | 2018 | 63 | 0.69 | Why? |
| Central Venous Catheters | 1 | 2019 | 188 | 0.67 | Why? |
| Hypothermia, Induced | 1 | 2019 | 176 | 0.67 | Why? |
| Urea | 1 | 2018 | 228 | 0.65 | Why? |
| Morpholines | 1 | 2018 | 351 | 0.62 | Why? |
| Sepsis | 6 | 2018 | 3517 | 0.61 | Why? |
| Intraoperative Complications | 1 | 2017 | 221 | 0.58 | Why? |
| Anti-Bacterial Agents | 8 | 2019 | 10083 | 0.58 | Why? |
| Adrenergic beta-Antagonists | 1 | 2018 | 465 | 0.55 | Why? |
| Ultrasonography | 7 | 2020 | 4409 | 0.53 | Why? |
| Nitrofurazone | 1 | 2012 | 1 | 0.52 | Why? |
| Analgesia, Epidural | 3 | 2018 | 63 | 0.52 | Why? |
| Precision Medicine | 3 | 2019 | 1477 | 0.52 | Why? |
| Carbon Dioxide | 1 | 2020 | 917 | 0.50 | Why? |
| Mesenteric Ischemia | 1 | 2015 | 128 | 0.49 | Why? |
| Urinary Catheterization | 1 | 2012 | 47 | 0.49 | Why? |
| Critical Care | 11 | 2021 | 14081 | 0.48 | Why? |
| Pneumonia, Ventilator-Associated | 2 | 2017 | 861 | 0.48 | Why? |
| Checklist | 1 | 2017 | 714 | 0.44 | Why? |
| Takotsubo Cardiomyopathy | 1 | 2017 | 453 | 0.43 | Why? |
| Trauma Centers | 3 | 2018 | 1195 | 0.43 | Why? |
| Lung Transplantation | 2 | 2018 | 1554 | 0.39 | Why? |
| Catheter-Related Infections | 1 | 2012 | 381 | 0.36 | Why? |
| Guideline Adherence | 2 | 2018 | 2309 | 0.36 | Why? |
| Norepinephrine | 2 | 2018 | 152 | 0.33 | Why? |
| Anesthesia | 1 | 2017 | 1236 | 0.33 | Why? |
| Urinary Tract Infections | 1 | 2012 | 534 | 0.32 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.32 | Why? |
| Wounds and Injuries | 5 | 2020 | 1708 | 0.31 | Why? |
| France | 15 | 2021 | 12074 | 0.30 | Why? |
| Pneumonectomy | 2 | 2018 | 278 | 0.28 | Why? |
| Vasoconstrictor Agents | 2 | 2018 | 714 | 0.26 | Why? |
| Epinephrine | 3 | 2018 | 323 | 0.23 | Why? |
| Hospital Mortality | 8 | 2021 | 22087 | 0.22 | Why? |
| Receptors, Prostaglandin | 1 | 2020 | 29 | 0.22 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.22 | Why? |
| Schizophrenia | 2 | 2021 | 1018 | 0.21 | Why? |
| Partial Pressure | 1 | 2020 | 279 | 0.20 | Why? |
| Granulocytes | 1 | 2020 | 140 | 0.20 | Why? |
| Epidural Space | 1 | 2018 | 12 | 0.19 | Why? |
| Myocardial Contusions | 1 | 2018 | 2 | 0.19 | Why? |
| Afibrinogenemia | 1 | 2018 | 10 | 0.19 | Why? |
| Pyloric Antrum | 1 | 2018 | 3 | 0.19 | Why? |
| Veins | 1 | 2020 | 168 | 0.19 | Why? |
| Gastrointestinal Contents | 1 | 2018 | 7 | 0.19 | Why? |
| Male | 40 | 2021 | 367725 | 0.18 | Why? |
| Preliminary Data | 1 | 2020 | 457 | 0.18 | Why? |
| Thoracotomy | 1 | 2018 | 85 | 0.18 | Why? |
| Delayed Graft Function | 1 | 2018 | 52 | 0.18 | Why? |
| Humans | 61 | 2021 | 930598 | 0.18 | Why? |
| Arteries | 1 | 2020 | 283 | 0.17 | Why? |
| Thoracic Vertebrae | 1 | 2018 | 97 | 0.17 | Why? |
| Anesthesia, Epidural | 1 | 2018 | 92 | 0.17 | Why? |
| Multiple Trauma | 1 | 2018 | 80 | 0.17 | Why? |
| Injury Severity Score | 1 | 2018 | 287 | 0.17 | Why? |
| Sex Factors | 3 | 2020 | 11014 | 0.17 | Why? |
| Lidocaine | 1 | 2018 | 94 | 0.17 | Why? |
| Thrombosis | 1 | 2019 | 7504 | 0.16 | Why? |
| Blood Vessel Prosthesis | 1 | 2017 | 115 | 0.16 | Why? |
| Peritonitis | 1 | 2019 | 217 | 0.16 | Why? |
| Equipment Failure | 1 | 2018 | 197 | 0.16 | Why? |
| Electronics | 1 | 2017 | 199 | 0.16 | Why? |
| Tomography, X-Ray Computed | 4 | 2020 | 25144 | 0.16 | Why? |
| Receptors, Immunologic | 1 | 2020 | 555 | 0.16 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.16 | Why? |
| Chlorhexidine | 1 | 2018 | 176 | 0.16 | Why? |
| Rats, Wistar | 1 | 2018 | 621 | 0.16 | Why? |
| Pregnancy Trimester, Third | 1 | 2018 | 445 | 0.16 | Why? |
| Cross Infection | 2 | 2018 | 8675 | 0.16 | Why? |
| Prospective Studies | 16 | 2021 | 43301 | 0.15 | Why? |
| Female | 36 | 2021 | 380317 | 0.15 | Why? |
| Multiple Organ Failure | 2 | 2017 | 1724 | 0.15 | Why? |
| Ultrasonic Therapy | 1 | 2015 | 43 | 0.15 | Why? |
| Comprehension | 1 | 2018 | 259 | 0.15 | Why? |
| Anesthetics, Local | 1 | 2018 | 205 | 0.15 | Why? |
| Aorta, Thoracic | 1 | 2017 | 271 | 0.14 | Why? |
| Nerve Block | 1 | 2018 | 183 | 0.14 | Why? |
| Incidental Findings | 1 | 2019 | 487 | 0.14 | Why? |
| Cephalosporins | 1 | 2017 | 250 | 0.14 | Why? |
| Blood Vessel Prosthesis Implantation | 1 | 2017 | 226 | 0.14 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2018 | 449 | 0.14 | Why? |
| Pain, Postoperative | 1 | 2018 | 289 | 0.14 | Why? |
| Middle Aged | 32 | 2021 | 270681 | 0.14 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.13 | Why? |
| Research Report | 1 | 2018 | 376 | 0.13 | Why? |
| Decision Trees | 1 | 2016 | 441 | 0.13 | Why? |
| Cyclosporine | 1 | 2018 | 449 | 0.13 | Why? |
| Abdomen | 1 | 2017 | 424 | 0.13 | Why? |
| Hypotension | 1 | 2017 | 392 | 0.13 | Why? |
| Organ Dysfunction Scores | 1 | 2020 | 1475 | 0.13 | Why? |
| Professional-Family Relations | 1 | 2018 | 424 | 0.13 | Why? |
| Mastectomy | 1 | 2018 | 536 | 0.13 | Why? |
| Retrospective Studies | 10 | 2021 | 105322 | 0.13 | Why? |
| Antimicrobial Stewardship | 2 | 2018 | 931 | 0.13 | Why? |
| Respiration, Artificial | 6 | 2021 | 22116 | 0.12 | Why? |
| Expert Testimony | 1 | 2017 | 658 | 0.12 | Why? |
| Aortic Diseases | 1 | 2017 | 362 | 0.12 | Why? |
| Magnetic Resonance Imaging | 3 | 2018 | 6551 | 0.12 | Why? |
| Patient Admission | 2 | 2021 | 5250 | 0.12 | Why? |
| Critical Illness | 6 | 2019 | 17281 | 0.12 | Why? |
| Aged | 26 | 2021 | 215776 | 0.12 | Why? |
| Point-of-Care Systems | 2 | 2017 | 2955 | 0.12 | Why? |
| Fibrinogen | 1 | 2018 | 1048 | 0.12 | Why? |
| Angiotensin Receptor Antagonists | 2 | 2019 | 3892 | 0.12 | Why? |
| Bipolar Disorder | 1 | 2020 | 744 | 0.12 | Why? |
| Propensity Score | 2 | 2018 | 2690 | 0.12 | Why? |
| Shock, Cardiogenic | 1 | 2018 | 700 | 0.11 | Why? |
| Anti-Infective Agents, Local | 1 | 2018 | 520 | 0.11 | Why? |
| Odds Ratio | 2 | 2020 | 5861 | 0.11 | Why? |
| National Health Programs | 1 | 2018 | 807 | 0.11 | Why? |
| Postoperative Complications | 3 | 2019 | 5861 | 0.11 | Why? |
| Lung Neoplasms | 2 | 2018 | 3228 | 0.11 | Why? |
| Positive-Pressure Respiration | 1 | 2019 | 1160 | 0.11 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 1115 | 0.10 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2019 | 5277 | 0.10 | Why? |
| Rats | 1 | 2018 | 2764 | 0.10 | Why? |
| Stents | 1 | 2017 | 916 | 0.10 | Why? |
| Disseminated Intravascular Coagulation | 1 | 2018 | 994 | 0.10 | Why? |
| Pancreatitis | 1 | 2018 | 688 | 0.10 | Why? |
| Chronic Pain | 1 | 2018 | 736 | 0.10 | Why? |
| Oropharynx | 1 | 2018 | 1581 | 0.10 | Why? |
| Monocytes | 2 | 2020 | 2978 | 0.10 | Why? |
| Ventricular Function, Left | 1 | 2018 | 1555 | 0.09 | Why? |
| Acute Kidney Injury | 2 | 2019 | 5762 | 0.09 | Why? |
| Leukocytes, Mononuclear | 1 | 2018 | 2115 | 0.09 | Why? |
| Blood Transfusion | 1 | 2018 | 1399 | 0.09 | Why? |
| Hospitals, University | 2 | 2020 | 4173 | 0.09 | Why? |
| Lymphocyte Activation | 1 | 2018 | 2742 | 0.09 | Why? |
| Heart | 1 | 2018 | 1791 | 0.09 | Why? |
| Tissue Donors | 1 | 2018 | 1679 | 0.09 | Why? |
| Terminal Care | 1 | 2018 | 928 | 0.09 | Why? |
| Continuous Positive Airway Pressure | 1 | 2017 | 1187 | 0.09 | Why? |
| Perioperative Care | 1 | 2019 | 1329 | 0.09 | Why? |
| Treatment Outcome | 7 | 2019 | 51732 | 0.09 | Why? |
| Stroke Volume | 1 | 2018 | 2153 | 0.09 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 1261 | 0.09 | Why? |
| Endovascular Procedures | 1 | 2017 | 1302 | 0.09 | Why? |
| Graft Rejection | 1 | 2018 | 1766 | 0.09 | Why? |
| Predictive Value of Tests | 2 | 2020 | 9537 | 0.09 | Why? |
| Glasgow Coma Scale | 2 | 2018 | 249 | 0.08 | Why? |
| Disease Susceptibility | 1 | 2020 | 4002 | 0.08 | Why? |
| Clinical Decision-Making | 2 | 2019 | 3755 | 0.08 | Why? |
| Monitoring, Physiologic | 1 | 2018 | 1956 | 0.08 | Why? |
| Pharmaceutical Preparations | 1 | 2021 | 1897 | 0.08 | Why? |
| Time Factors | 6 | 2019 | 31397 | 0.08 | Why? |
| Elastin | 1 | 2005 | 16 | 0.08 | Why? |
| Anesthesiology | 1 | 2017 | 1163 | 0.08 | Why? |
| Severity of Illness Index | 6 | 2020 | 48226 | 0.08 | Why? |
| Fibrin Fibrinogen Degradation Products | 2 | 2020 | 5993 | 0.08 | Why? |
| Adult | 17 | 2021 | 244371 | 0.07 | Why? |
| Databases, Factual | 1 | 2020 | 6248 | 0.07 | Why? |
| Randomized Controlled Trials as Topic | 3 | 2019 | 10649 | 0.07 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.07 | Why? |
| Risk Factors | 7 | 2020 | 71621 | 0.07 | Why? |
| Length of Stay | 2 | 2020 | 11042 | 0.07 | Why? |
| Single-Blind Method | 2 | 2019 | 1283 | 0.07 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.07 | Why? |
| Guidelines as Topic | 1 | 2017 | 2844 | 0.07 | Why? |
| Family | 1 | 2018 | 2909 | 0.07 | Why? |
| Atrial Fibrillation | 1 | 2018 | 2320 | 0.07 | Why? |
| Kidney | 1 | 2018 | 3648 | 0.06 | Why? |
| Logistic Models | 2 | 2017 | 9089 | 0.06 | Why? |
| Renal Insufficiency, Chronic | 1 | 2018 | 2654 | 0.06 | Why? |
| Renin-Angiotensin System | 1 | 2019 | 3661 | 0.06 | Why? |
| Healthcare Disparities | 1 | 2021 | 3893 | 0.06 | Why? |
| Cause of Death | 1 | 2017 | 4823 | 0.06 | Why? |
| Lung | 3 | 2020 | 31049 | 0.06 | Why? |
| Stress Disorders, Post-Traumatic | 1 | 2019 | 2963 | 0.06 | Why? |
| Double-Blind Method | 3 | 2018 | 5988 | 0.06 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.06 | Why? |
| Drug Administration Schedule | 2 | 2019 | 2324 | 0.06 | Why? |
| Intubation, Intratracheal | 1 | 2017 | 3962 | 0.06 | Why? |
| Multicenter Studies as Topic | 2 | 2019 | 2437 | 0.06 | Why? |
| CD11b Antigen | 1 | 2020 | 90 | 0.05 | Why? |
| Cohort Studies | 6 | 2021 | 36005 | 0.05 | Why? |
| Pulmonary Embolism | 1 | 2020 | 4775 | 0.05 | Why? |
| Aged, 80 and over | 8 | 2021 | 88759 | 0.05 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.05 | Why? |
| T-Lymphocytes | 1 | 2018 | 6670 | 0.05 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.05 | Why? |
| Communication | 1 | 2018 | 5206 | 0.05 | Why? |
| Societies, Medical | 1 | 2017 | 6907 | 0.05 | Why? |
| Emergency Medical Services | 1 | 2017 | 3557 | 0.05 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.05 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.05 | Why? |
| Immunosuppressive Agents | 1 | 2018 | 6331 | 0.05 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.05 | Why? |
| Nasopharynx | 1 | 2018 | 10224 | 0.05 | Why? |
| Peptide Mapping | 1 | 2018 | 112 | 0.05 | Why? |
| Antilymphocyte Serum | 1 | 2018 | 80 | 0.05 | Why? |
| Infusion Pumps | 1 | 2018 | 44 | 0.05 | Why? |
| Adolescent | 5 | 2020 | 86841 | 0.05 | Why? |
| Quality of Life | 1 | 2019 | 9820 | 0.04 | Why? |
| Kidney Transplantation | 1 | 2018 | 5397 | 0.04 | Why? |
| Oligonucleotides | 1 | 2018 | 137 | 0.04 | Why? |
| Monitoring, Immunologic | 1 | 2018 | 153 | 0.04 | Why? |
| Bacteria | 2 | 2019 | 1897 | 0.04 | Why? |
| Supine Position | 1 | 2018 | 158 | 0.04 | Why? |
| Heart Failure | 1 | 2019 | 6638 | 0.04 | Why? |
| Nonlinear Dynamics | 1 | 2018 | 177 | 0.04 | Why? |
| CpG Islands | 1 | 2018 | 230 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.04 | Why? |
| Hypertension | 1 | 2019 | 8895 | 0.04 | Why? |
| Shock, Hemorrhagic | 1 | 2017 | 81 | 0.04 | Why? |
| Tidal Volume | 1 | 2019 | 565 | 0.04 | Why? |
| Disease Progression | 3 | 2020 | 13580 | 0.04 | Why? |
| Quality-Adjusted Life Years | 1 | 2019 | 511 | 0.04 | Why? |
| Pilot Projects | 2 | 2018 | 5182 | 0.04 | Why? |
| HLA-DR Antigens | 1 | 2018 | 563 | 0.04 | Why? |
| Proportional Hazards Models | 2 | 2019 | 6543 | 0.04 | Why? |
| Intention to Treat Analysis | 1 | 2017 | 673 | 0.04 | Why? |
| Immunophenotyping | 1 | 2020 | 1290 | 0.04 | Why? |
| Gram-Positive Bacteria | 1 | 2017 | 230 | 0.04 | Why? |
| Pressure | 1 | 2017 | 289 | 0.04 | Why? |
| Oximetry | 1 | 2020 | 658 | 0.04 | Why? |
| Circadian Rhythm | 1 | 2021 | 607 | 0.04 | Why? |
| Graft Survival | 1 | 2018 | 587 | 0.04 | Why? |
| Pain Measurement | 1 | 2018 | 533 | 0.04 | Why? |
| Peptide Fragments | 1 | 2005 | 2075 | 0.03 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.03 | Why? |
| Survival Rate | 2 | 2019 | 9206 | 0.03 | Why? |
| Russia | 1 | 2018 | 989 | 0.03 | Why? |
| Blood Pressure Determination | 1 | 2017 | 450 | 0.03 | Why? |
| Lipopolysaccharides | 1 | 2018 | 848 | 0.03 | Why? |
| Age Factors | 1 | 2015 | 21039 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2019 | 1262 | 0.03 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2018 | 1654 | 0.03 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2017 | 669 | 0.03 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2017 | 323 | 0.03 | Why? |
| Blood Coagulation Tests | 1 | 2018 | 855 | 0.03 | Why? |
| Interleukin-6 | 2 | 2021 | 7522 | 0.03 | Why? |
| Drug Resistance, Microbial | 1 | 2017 | 419 | 0.03 | Why? |
| Rehabilitation | 1 | 2018 | 386 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Gram-Negative Bacteria | 1 | 2017 | 473 | 0.03 | Why? |
| Postoperative Care | 1 | 2017 | 755 | 0.03 | Why? |
| Biomarkers | 3 | 2020 | 23361 | 0.03 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2017 | 398 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2018 | 15909 | 0.03 | Why? |
| Ferritins | 1 | 2020 | 2055 | 0.03 | Why? |
| Interleukin-10 | 1 | 2018 | 1409 | 0.03 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.03 | Why? |
| Young Adult | 5 | 2020 | 93724 | 0.03 | Why? |
| Gene Expression | 1 | 2021 | 3332 | 0.03 | Why? |
| Leukocyte Count | 1 | 2020 | 3178 | 0.03 | Why? |
| Hemodynamics | 1 | 2018 | 1562 | 0.03 | Why? |
| Respiratory Tract Diseases | 1 | 2017 | 1061 | 0.02 | Why? |
| Cooperative Behavior | 1 | 2017 | 1216 | 0.02 | Why? |
| Drug Monitoring | 1 | 2017 | 1408 | 0.02 | Why? |
| Decontamination | 1 | 2018 | 1196 | 0.02 | Why? |
| Animals | 1 | 2018 | 78931 | 0.02 | Why? |
| Interferon-gamma | 1 | 2018 | 2711 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.02 | Why? |
| Preoperative Care | 1 | 2018 | 1515 | 0.02 | Why? |
| Lymphocytes | 1 | 2020 | 3056 | 0.02 | Why? |
| Prone Position | 1 | 2019 | 1861 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Kidney Diseases | 1 | 2017 | 1434 | 0.02 | Why? |
| Emotions | 1 | 2018 | 2418 | 0.02 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.02 | Why? |
| Germany | 1 | 2020 | 9196 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Echocardiography | 1 | 2018 | 3661 | 0.02 | Why? |
| Patient Discharge | 1 | 2019 | 5696 | 0.02 | Why? |
| Reference Values | 1 | 2005 | 795 | 0.01 | Why? |
| Emergencies | 1 | 2017 | 4095 | 0.01 | Why? |
| Surgical Procedures, Operative | 1 | 2017 | 2662 | 0.01 | Why? |
| Education, Medical | 1 | 2018 | 2461 | 0.01 | Why? |
| Europe | 1 | 2017 | 12702 | 0.01 | Why? |
| Breast Neoplasms | 1 | 2018 | 3633 | 0.01 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.01 | Why? |
| Models, Theoretical | 1 | 2018 | 6659 | 0.01 | Why? |
| Triage | 1 | 2018 | 7151 | 0.01 | Why? |
| Registries | 1 | 2018 | 12327 | 0.01 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2017 | 6653 | 0.01 | Why? |
| Respiratory Insufficiency | 1 | 2018 | 7301 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Italy | 1 | 2020 | 38444 | 0.01 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.01 | Why? |
| Stress, Psychological | 1 | 2018 | 10231 | 0.01 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
| Depression | 1 | 2018 | 14116 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Anxiety | 1 | 2018 | 17311 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2017 | 11497 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 7868 | 0.01 | Why? |
| Aging | 1 | 2005 | 3581 | 0.01 | Why? |